{"id":12545,"date":"2021-10-20T09:00:07","date_gmt":"2021-10-20T14:00:07","guid":{"rendered":"https:\/\/backup.primeaction.com\/sp\/?p=12545"},"modified":"2021-10-18T23:05:16","modified_gmt":"2021-10-19T04:05:16","slug":"bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico","status":"publish","type":"post","link":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/","title":{"rendered":"Bayer acusa rechazo \u00abno cient\u00edfico\u00bb de Cofepris a permiso de ma\u00edz transg\u00e9nico"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg\" width=\"1120\" height=\"630\" class=\"aligncenter size-medium lazyload\" \/><noscript><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg\" width=\"1120\" height=\"630\" class=\"aligncenter size-medium\" \/><\/noscript><\/p>\n<p>Bayer est\u00e1 evaluando sus opciones legales despu\u00e9s de que reguladores sanitarios mexicanos rechazaran por primera vez otorgarle un permiso de ma\u00edz transg\u00e9nico que hab\u00eda solicitado, dijo el viernes el gigante farmac\u00e9utico y de cultivos alem\u00e1n, criticando la decisi\u00f3n como \u00abno cient\u00edfica\u00bb.<\/p>\n<p>Se inform\u00f3 temprano este viernes que la Cofepris rechaz\u00f3 conceder el aval para una nueva variedad de ma\u00edz, algo que requer\u00eda para su futura importaci\u00f3n a M\u00e9xico, en una se\u00f1al del endurecimiento de la posici\u00f3n del gobierno a los cultivos gen\u00e9ticamente modificados.<\/p>\n<p>\u00abEstamos decepcionados por las razones no cient\u00edficas por las que Cofepris deneg\u00f3 la aprobaci\u00f3n en M\u00e9xico\u00bb, dijo Bayer, que identific\u00f3 que la variedad de ma\u00edz rechazada utiliza su tecnolog\u00eda propia HT3 x SmartStax Pro.<\/p>\n<p>Bayer subray\u00f3 que la negaci\u00f3n del permiso no afecta su negocio actual y se\u00f1al\u00f3 que el a\u00f1o pasado la empresa dej\u00f3 de trabajar en sus variedades h\u00edbridas de ma\u00edz HT3 debido a los retrasos reglamentarios en la Uni\u00f3n Europea en favor de una nueva l\u00ednea HT4 que la empresa espera lanzar m\u00e1s tarde esta d\u00e9cada.<\/p>\n<p>No obstante, Bayer critic\u00f3 lo que describi\u00f3 como continuos retrasos regulatorios de la Cofepris, as\u00ed como la posibilidad de que se nieguen m\u00e1s permisos que podr\u00edan tener un \u00abimpacto devastador\u00bb en las cadenas de suministro mexicanas.<\/p>\n<p>La empresa dijo que los cultivos modificados gen\u00e9ticamente, incluido el ma\u00edz, han sido sometidos a m\u00e1s pruebas de seguridad que \u00abcualquier otro cultivo en la historia de la agricultura\u00bb y han sido considerados seguros para los seres humanos, los animales y el medio ambiente.<\/p>\n<p>La oficina de prensa de la Cofepris no respondi\u00f3 a las m\u00faltiples solicitudes de comentarios.<\/p>\n<p>El presidente mexicano, Andr\u00e9s Manuel L\u00f3pez Obrador, emiti\u00f3 un controvertido decreto a finales del a\u00f1o pasado que esbozaba un plan de tres a\u00f1os para prohibir el herbicida glifosato y el ma\u00edz transg\u00e9nico para el consumo humano.<\/p>\n<p>Las asociaciones de la industria han criticado duramente el plan y han intentado sin \u00e9xito frenar el plan en tribunales, argumentando que se corre el riesgo de una disputa comercial con Estados Unidos.<\/p>\n<p>Si se interpreta que la prohibici\u00f3n incluye al ma\u00edz para alimentaci\u00f3n de ganado u otros usos industriales, dicen que en \u00faltima instancia afectar\u00e1 a los consumidores con precios m\u00e1s altos de los alimentos.<\/p>\n<p>La prohibici\u00f3n prevista, sin embargo, es popular entre ecologistas y los defensores de la salud alimentaria que argumentan que la pulverizaci\u00f3n de glifosato en los cultivos transg\u00e9nicos dise\u00f1ados para tolerarlos es realmente perjudicial.<\/p>\n<p>El glifosato fue promovido por la marca de herbicidas Roundup de la empresa agroqu\u00edmica Monsanto, que fue comprada por Bayer como parte de una adquisici\u00f3n de 63,000 millones de d\u00f3lares en 2018.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bayer est\u00e1 evaluando sus opciones legales despu\u00e9s de que reguladores sanitarios mexicanos rechazaran por primera vez otorgarle un permiso de ma\u00edz transg\u00e9nico que hab\u00eda solicitado, dijo el viernes el gigante farmac\u00e9utico y de cultivos alem\u00e1n, criticando la decisi\u00f3n como \u00abno cient\u00edfica\u00bb. Se inform\u00f3 temprano este viernes que la Cofepris rechaz\u00f3 conceder el aval para una [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":12547,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-post.php","format":"standard","meta":{"_eb_attr":"","site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_mbp_gutenberg_autopost":false,"fifu_image_url":"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg","fifu_image_alt":"Bayer acusa rechazo &#8220;no cient\u00edfico&#8221; de Cofepris a permiso de ma\u00edz transg\u00e9nico","footnotes":""},"categories":[6],"tags":[],"class_list":["post-12545","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-post-agronegocios"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bayer acusa rechazo &quot;no cient\u00edfico&quot; de Cofepris a permiso de ma\u00edz transg\u00e9nico &#183; Prime Action Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayer acusa rechazo &quot;no cient\u00edfico&quot; de Cofepris a permiso de ma\u00edz transg\u00e9nico &#183; Prime Action Consulting\" \/>\n<meta property=\"og:description\" content=\"Bayer est\u00e1 evaluando sus opciones legales despu\u00e9s de que reguladores sanitarios mexicanos rechazaran por primera vez otorgarle un permiso de ma\u00edz transg\u00e9nico que hab\u00eda solicitado, dijo el viernes el gigante farmac\u00e9utico y de cultivos alem\u00e1n, criticando la decisi\u00f3n como \u00abno cient\u00edfica\u00bb. Se inform\u00f3 temprano este viernes que la Cofepris rechaz\u00f3 conceder el aval para una [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/\" \/>\n<meta property=\"og:site_name\" content=\"Prime Action Consulting\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-20T14:00:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg\" \/>\n<meta name=\"author\" content=\"primeactionmx\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"primeactionmx\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bayer acusa rechazo \"no cient\u00edfico\" de Cofepris a permiso de ma\u00edz transg\u00e9nico &#183; Prime Action Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/","og_locale":"es_ES","og_type":"article","og_title":"Bayer acusa rechazo \"no cient\u00edfico\" de Cofepris a permiso de ma\u00edz transg\u00e9nico &#183; Prime Action Consulting","og_description":"Bayer est\u00e1 evaluando sus opciones legales despu\u00e9s de que reguladores sanitarios mexicanos rechazaran por primera vez otorgarle un permiso de ma\u00edz transg\u00e9nico que hab\u00eda solicitado, dijo el viernes el gigante farmac\u00e9utico y de cultivos alem\u00e1n, criticando la decisi\u00f3n como \u00abno cient\u00edfica\u00bb. Se inform\u00f3 temprano este viernes que la Cofepris rechaz\u00f3 conceder el aval para una [&hellip;]","og_url":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/","og_site_name":"Prime Action Consulting","article_published_time":"2021-10-20T14:00:07+00:00","og_image":[{"url":"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg","type":"","width":"","height":""}],"author":"primeactionmx","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg","twitter_misc":{"Escrito por":"primeactionmx","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/#article","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/"},"author":{"name":"primeactionmx","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471"},"headline":"Bayer acusa rechazo \u00abno cient\u00edfico\u00bb de Cofepris a permiso de ma\u00edz transg\u00e9nico","datePublished":"2021-10-20T14:00:07+00:00","mainEntityOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/"},"wordCount":499,"publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg","articleSection":["Post Agronegocios"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/","url":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/","name":"Bayer acusa rechazo \"no cient\u00edfico\" de Cofepris a permiso de ma\u00edz transg\u00e9nico &#183; Prime Action Consulting","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/#primaryimage"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg","datePublished":"2021-10-20T14:00:07+00:00","breadcrumb":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/#primaryimage","url":"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg","contentUrl":"https:\/\/www.eleconomista.com.mx\/__export\/1626752792303\/sites\/eleconomista\/img\/2021\/07\/19\/maiz_reuters_x5x.jpg_423392900.jpg","caption":"Bayer acusa rechazo &#8220;no cient\u00edfico&#8221; de Cofepris a permiso de ma\u00edz transg\u00e9nico"},{"@type":"BreadcrumbList","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-acusa-rechazo-no-cientifico-de-cofepris-a-permiso-de-maiz-transgenico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/backup.primeaction.com\/sp\/"},{"@type":"ListItem","position":2,"name":"Bayer acusa rechazo \u00abno cient\u00edfico\u00bb de Cofepris a permiso de ma\u00edz transg\u00e9nico"}]},{"@type":"WebSite","@id":"https:\/\/backup.primeaction.com\/sp\/#website","url":"https:\/\/backup.primeaction.com\/sp\/","name":"Prime Action Consulting","description":"Consultoria Especializada em Canais","publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/backup.primeaction.com\/sp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/backup.primeaction.com\/sp\/#organization","name":"Prime Action Consulting","url":"https:\/\/backup.primeaction.com\/sp\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/","url":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","contentUrl":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","width":400,"height":185,"caption":"Prime Action Consulting"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471","name":"primeactionmx","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","caption":"primeactionmx"},"url":"https:\/\/backup.primeaction.com\/sp\/author\/primeactionmx\/"}]}},"_links":{"self":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/12545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/comments?post=12545"}],"version-history":[{"count":1,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/12545\/revisions"}],"predecessor-version":[{"id":12546,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/12545\/revisions\/12546"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media\/12547"}],"wp:attachment":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media?parent=12545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/categories?post=12545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/tags?post=12545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}